WFA
AVNS icon

Wipfli Financial Advisors’s Avanos Medical AVNS Stock Holding History

Wipfli Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Buy
+72
New +$1.88K ﹤0.01% 2263

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wipfli Financial Advisors's AVNS Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Avanos Medical (AVNS) in Q3 2022: 72 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2263 among its holdings.

274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

  • Wipfli Financial Advisors held 72 shares of Avanos Medical worth $2K as of Q3 2022.
  • Avanos Medical was a new Wipfli Financial Advisors position in Q3 2022.
  • Avanos Medical made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2263 holding.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.